Oriola

0.89 EUR

-0.67 %

Corporate customer

OKDBV

NASDAQ Helsinki

Medical Equipment & Services

Health Care

7,638 following

Compare

-0.67%

-5.12%

-1.87%

-0.67%

-18.2%

-14.91%

-54.41%

-56.37%

-51.61%

Oriola is a pharmaceutical group with a special focus on the distribution of pharmaceuticals to other companies in the industry. The company offers services to pharmacies and other pharmaceutical companies, which includes, for example, negotiations with suppliers and distribution of products. The largest presence is in the Nordic and Baltic countries. The head office is located in Espoo.

Market cap

161.52M EUR

Turnover

284.32K EUR

P/E (adj.) (24e)

23.76

EV/EBIT (adj.) (24e)

3.73

P/B (24e)

1.02

EV/S (24e)

0.05

Dividend yield-% (24e)

8.99 %

Coverage

Recommendation

Accumulate

Target price

1.00 EUR

Updated

2024-12-16

Disclaimer

Financial calendar

4/3

2025

Annual report '24

2/4

2025

General meeting '24

29/4

2025

Interim report Q1'25

Risk

Business risk

Valuation risk

Low

High

ShowingAll content types

Regulatory press release12/19/2024, 12:00 PM

Oriola Oyj: Oriola to record an impairment of approximately EUR 16 million related to its joint venture Kronans Apotek

Oriola

Regulatory press release12/11/2024, 7:15 AM

Oriola Oyj: Oriola renews operating model and management team to accelerate strategy execution

Oriola

Press release11/20/2024, 8:00 AM

Oriola Oyj: The Swedish Patent and Market Court rejected Apotekstjänst Sverige AB's appeal regarding the sale of Svensk dos AB

Oriola

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account

Followings and notifications on followed companies

Analyst comments and recommendations

Stock comparison tool & other popular tools

Create account

Video10/30/2024, 1:15 PM by

Rauli Juva

Oriola Q3’24: Building the foundation

Changes in Oriola’s management group continued, with the focus now on creating a sustainable foundation. Despite achieving strong revenue growth, Oriola unexpectedly recorded substantial one-time costs related to the ERP project.

Oriola

Webcast10/30/2024, 8:00 AM

Oriola-KD Oyj, Q3'24

Oriola

Regulatory press release10/30/2024, 6:30 AM

Oriola Oyj: Oriola Corporation's Interim Report January-September 2024

Oriola

Press release10/16/2024, 6:00 AM

Oriola Oyj: Oriola Corporation to publish its Interim Report for January-September 2024 on 30 October 2024

Oriola

Regulatory press release10/11/2024, 5:30 AM

Oriola Oyj: Change in Oriola Management Team: Hannes Hasselrot, Chief Commercial Officer, to leave Oriola

Oriola

Regulatory press release10/7/2024, 6:30 AM

Oriola Oyj: Oriola appoints Tuomas Tiilikainen as Chief Supply Chain Officer

Oriola

Regulatory press release8/29/2024, 5:45 AM

Oriola Oyj: Publication schedule for Oriola Corporation's financial reporting in 2025

Oriola

Regulatory press release8/29/2024, 5:30 AM

Oriola Oyj: Oriola appoints Mats Danielsson as Chief Financial Officer

Oriola

Regulatory press release8/14/2024, 7:30 AM

Oriola Oyj: Changes in Oriola's Management Team: Timo Leinonen and Petri Boman to leave Oriola

Oriola

Video7/18/2024, 10:35 AM by

Rauli Juva

Oriola Q2’24: Sales growth in both segments

Oriola’s Q2 earnings were quite in line with our estimates and the guidance for the whole year of 2024 remained unchanged. The joint venture company in Sweden performed better than we expected after two very weak quarters. CEO Katarina Gabrielson comments on the Q2 result in this interview.

Oriola

Webcast7/18/2024, 7:00 AM

Oriola

0.89

EUR